All articles by Andy Extance – Page 9
-
NewsExplainer: non-alcoholic beer and wine
For Dry January and beyond, drinkers are thirsty for beers and wines that don’t get you drunk
-
ResearchSynthetic gene cost slashed to $2
DropSynth makes hundreds of strands in a single tube, boosting tests of gene function
-
BusinessTeva to cut 14,000 jobs
Saddled with debt in an increasingly competitive generic drug industry, the Israel-headquartered giant begins a difficult transformation
-
ResearchDNA origami makes it big
Researchers build complex DNA structures that are larger than ever before
-
FeatureBeer: Music to your taste buds
Andy Extance goes on tour in the UK and Belgium and compares the science behind the different processes used by craft and mass brewers
-
ResearchMolten metal enables climate-friendly hydrogen production
Discovery from academics collaborating with Shell could enable a sustainable energy future, with a reduced global warming threat
-
-
ResearchComputer reconstruction gives microscopy 100-fold precision boost
Confocal microscopy enhancement costing just a few dollars per image could be applied to all imaging
-
ResearchFirst liquid MOF could get material discovery flowing
Data and modelling show framework and porous structure are retained after melting
-
FeatureThe rising tide of 'legal highs'
Andy Extance investigates the chemistry that has helped recreational drugs evade the law, and its consequences
-
NewsNitrous oxide causes UK drug law confusion
Successful defences based on laughing gas’ medical uses follow prominent convictions that have resulted in a legal lottery
-
ResearchChemists find the σ-hole reason gold catalysts work
Calculations show low electron density makes nanoparticle corners and edges reactive
-
ResearchStructural sleuthing salvages superbug slayer
Combining ‘assembly line’ synthesis, spectroscopy and computational predictions solves stereochemistry riddle
-
BusinessGSK stops over 30 research programmes to prioritise innovation
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
-
BusinessAstraZeneca shares tumble after antibody failure
Imfinzi and tremelimumab checkpoint inhibitor pairing fails to beat chemotherapy in lung cancer
-
BusinessNovartis coasts towards first CAR-T approval
Unanimous recommendation for CTL019 ahead of October decision builds confidence in T-cell genetic reprogramming
-
ResearchSaturn ring-like ‘streaming’ takes liquids into a new world
Equatorial rings that break up into uniform microdroplets could be an alternative to microfluidic emulsification techniques
-
CareersWould you rent your lab equipment?
Virtual sharing and equopment loans are making access to vital research tools easier
-
ResearchEnergy storage prices forecast to tumble
First broad ‘evidence-based’ comparison shows similar capital cost evolution among technologies including lithium-ion and flow batteries
-
ResearchChemists unravel why humans aren’t constantly bursting into flames
Strong π-bonding holds the secret to taming dioxygen diradicals